1-4 of 4
Nicholas D. Huntington
Close
Sort by
Journal Articles

IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos

Pasquale L. Fedele, Simon N. Willis, Yang Liao, Michael S. Low, Jai Rautela, David H. Segal, Jia-Nan Gong, Nicholas D. Huntington, Wei Shi, David C. S. Huang, George Grigoriadis, Julie Tellier, Stephen L. Nutt
Journal: Blood
Blood (2018) 132 (20): 2166–2178.
https://doi.org/10.1182/blood-2018-05-850727
Published: 2018
Includes: Supplemental data
Journal Articles

GVHD prevents NK-cell–dependent leukemia and virus-specific innate immunity

Mark D. Bunting, Antiopi Varelias, Fernando Souza-Fonseca-Guimaraes, Iona S. Schuster, Katie E. Lineburg, Rachel D. Kuns, Peter Fleming, Kelly R. Locke, Nicholas D. Huntington, Bruce R. Blazar, Steven W. Lane, Siok-Keen Tey, Kelli P. A. MacDonald, Mark J. Smyth, Mariapia A. Degli-Esposti, Geoffrey R. Hill
Journal: Blood
Blood (2017) 129 (5): 630–642.
https://doi.org/10.1182/blood-2016-08-734020
Published: 2017
Includes: Supplemental data
Journal Articles

A crucial role for the homeodomain transcription factor Hhex in lymphopoiesis

Jacob T. Jackson, Chayanica Nasa, Wei Shi, Nicholas D. Huntington, Clifford W. Bogue, Warren S. Alexander, Matthew P. McCormack
Journal: Blood
Blood (2015) 125 (5): 803–814.
https://doi.org/10.1182/blood-2014-06-579813
Published: 2015
Includes: Supplemental data
Journal Articles

A role for Blimp1 in the transcriptional network controlling natural killer cell maturation

Axel Kallies, Sebastian Carotta, Nicholas D. Huntington, Nicholas J. Bernard, David M. Tarlinton, Mark J. Smyth, Stephen L. Nutt
Journal: Blood
Blood (2011) 117 (6): 1869–1879.
https://doi.org/10.1182/blood-2010-08-303123
Published: 2011
Includes: Supplemental data